Clinical Trial Update: Initiation of Insulin Aspart in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial investigating insulin aspart for type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED